Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...

Danish biotechnology company Zealand Pharma said on Thursday it had enrolled the first patient in a mid-stage trial with its weight-loss drug candidate petrelintide in people with overweight or ...

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

During the three-day visit, the Swiss delegation will highlight Switzerland’s substantial investments in the United States, ...

While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily ...

European drug company bosses say the answer to a perceived lack of competitiveness in the EU is to hike medicine prices to US ...

U.S. President Donald Trump has backed away from his threats to fire Jerome Powell after days of criticising the Federal ...

They're not just leaders of their industry. Their underlying businesses are also on the verge of enormous growth.